These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24952199)

  • 1. Proteomic approaches to dissect neuronal signaling pathways.
    Bowling HL; Deinhardt K
    Adv Exp Med Biol; 2014; 806():499-508. PubMed ID: 24952199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Approaches to Dissect Neuronal Signalling Pathways.
    Bowling HL; Nayak S; Deinhardt K
    Adv Exp Med Biol; 2019; 1140():469-475. PubMed ID: 31347065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nerve growth factor system in health and disease].
    Kliushnik TP
    Vestn Ross Akad Med Nauk; 1999; (1):25-8. PubMed ID: 10078059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure out of chaos: functional brain network analysis with EEG, MEG, and functional MRI.
    van Straaten EC; Stam CJ
    Eur Neuropsychopharmacol; 2013 Jan; 23(1):7-18. PubMed ID: 23158686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding mental disorders from neuronal networks to glial cells and proteomics.
    Falkai P; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2010 Sep; 260(6):441-2. PubMed ID: 20845022
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurotrophins and their receptors--current concepts and implications for neurologic disease.
    Eide FF; Lowenstein DH; Reichardt LF
    Exp Neurol; 1993 Jun; 121(2):200-14. PubMed ID: 8339771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins.
    Mocchetti I
    Cell Mol Life Sci; 2005 Oct; 62(19-20):2283-94. PubMed ID: 16158191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain, networks, depression, and more.
    Leistedt SJ; Linkowski P
    Eur Neuropsychopharmacol; 2013 Jan; 23(1):55-62. PubMed ID: 23154052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The time course of nerve growth factor content in different neuropsychiatric diseases--a unifying hypothesis.
    Hellweg R; von Richthofen S; Anders D; Baethge C; Röpke S; Hartung HD; Gericke CA
    J Neural Transm (Vienna); 1998; 105(8-9):871-903. PubMed ID: 9869324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light and chemical control of neuronal circuits: possible applications in neurotherapy.
    Whittle AJ; Walsh J; de Lecea L
    Expert Rev Neurother; 2014 Sep; 14(9):1007-17. PubMed ID: 25115180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens.
    von Bartheld CS
    J Neurobiol; 2004 Feb; 58(2):295-314. PubMed ID: 14704960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurodevelopmental role of dopaminergic signaling in neurological disorders.
    Cai Y; Xing L; Yang T; Chai R; Wang J; Bao J; Shen W; Ding S; Chen G
    Neurosci Lett; 2021 Jan; 741():135540. PubMed ID: 33278505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations.
    Lang UE; Jockers-Scherübl MC; Hellweg R
    J Neural Transm (Vienna); 2004 Mar; 111(3):387-411. PubMed ID: 14991461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal intracellular dynamics of neurotrophin and its receptors. Implications for neurotrophin signaling and neuronal function.
    Bronfman FC; Lazo OM; Flores C; Escudero CA
    Handb Exp Pharmacol; 2014; 220():33-65. PubMed ID: 24668469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods.
    Fonteh AN; Harrington RJ; Huhmer AF; Biringer RG; Riggins JN; Harrington MG
    Dis Markers; 2006; 22(1-2):39-64. PubMed ID: 16410651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophic regulation of retinal ganglion cell synaptic connectivity: from axons and dendrites to synapses.
    Cohen-Cory S; Lom B
    Int J Dev Biol; 2004; 48(8-9):947-56. PubMed ID: 15558485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the neuronal network activity by P2X receptors and their involvement in neurological disorders.
    Sáez-Orellana F; Godoy PA; Silva-Grecchi T; Barra KM; Fuentealba J
    Pharmacol Res; 2015 Nov; 101():109-15. PubMed ID: 26122853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine D2 receptor: new surprises from an old friend.
    Bonci A; Hopf FW
    Neuron; 2005 Aug; 47(3):335-8. PubMed ID: 16055058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review on Graph Clustering and Subgraph Similarity Based Analysis of Neurological Disorders.
    Thomas J; Seo D; Sael L
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27258269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connecting Brain Proteomics with Behavioural Neuroscience in Translational Animal Models of Neuropsychiatric Disorders.
    Sarnyai Z; Guest PC
    Adv Exp Med Biol; 2017; 974():97-114. PubMed ID: 28353227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.